Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ritalinic Acid

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 461Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ADHD drug tied to heart defects in babies
    ADHD drug tied to heart defects in babies

    08 Jan 2018

    // Lisa Rapaport REUTERS

    https://www.reuters.com/article/us-health-adhd-pregnancy-defects/adhd-drug-tied-to-heart-defects-in-babies-idUSKBN1EU1ZY?feedType=RSS&feedName=healthNews

    Lisa Rapaport REUTERS
    08 Jan 2018
    Share Share
    Indian pharma snaps up U.S. manufacturing with $1.5B worth of deals in 2015
    Indian pharma snaps up U.S. manufacturing with $1.5B worth of deals in 2015

    26 Feb 2016

    // Eric Palmer FIERCE PHARMA MANUFACTURING

    http://www.fiercepharmamanufacturing.com/story/indian-pharma-snaps-us-manufacturing-15b-worth-deals-2015/2016-02-25

    Eric Palmer FIERCE PHARMA MANUFACTURING
    26 Feb 2016
    Share Share
    Generic A.D.H.D. Drug, Not Equivalent to the Brand, Is in Use Anyway
    Generic A.D.H.D. Drug, Not Equivalent to the Brand, Is in Use Anyway

    16 Jun 2015

    // Katie Thomas THE NEW YORK TIMES

    http://www.nytimes.com/2015/06/17/business/generic-ritalin-drug-not-equivalent-to-the-brand-is-in-use-anyway.html?partner=rss&emc=rss&_r=0

    Katie Thomas THE NEW YORK TIMES
    16 Jun 2015
    Share Share